Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10908772 | Leukemia Research | 2014 | 6 Pages |
Abstract
MGMT promoter methylation predicts dacarbazine sensitivity of HL cells and it might be interesting to analyze this factor in HL patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Stefanie Kewitz, Martina Stiefel, Christof M. Kramm, Martin S. Staege,